Company Registration No. 13498615 (England and Wales)
Farooq Pharma Ltd
Unaudited accounts
for the year ended 31 July 2025
Farooq Pharma Ltd
Accountants' report
Accountants' report to the director of Farooq Pharma Ltd on the preparation of the unaudited statutory accounts for the year ended 31 July 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of
Farooq Pharma Ltd for the year ended
31 July 2025 as set out on pages
3 -
5 from the company's accounting records and from information and explanations you have given us.
This report is made solely to the Board of Directors of Farooq Pharma Ltd, as a body, in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the accounts of Farooq Pharma Ltd and state those matters that we have agreed to state to them, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Farooq Pharma Ltd and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Farooq Pharma Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Farooq Pharma Ltd. You consider that Farooq Pharma Ltd is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of Farooq Pharma Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
Sigmatax
J O Hunter House
409 Bradford Road
Huddersfield
West Yorkshire
HD2 2RB
18 December 2025
Farooq Pharma Ltd
Statement of financial position
as at 31 July 2025
Tangible assets
16,900
13,609
Cash at bank and in hand
7,134
76,499
Creditors: amounts falling due within one year
(6,298)
(7,986)
Net current assets
1,169
68,835
Total assets less current liabilities
18,069
82,444
Creditors: amounts falling due after more than one year
-
(13,882)
Provisions for liabilities
Deferred tax
(3,211)
(2,593)
Called up share capital
10
10
Profit and loss account
14,848
65,959
Shareholders' funds
14,858
65,969
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 18 December 2025 and were signed on its behalf by
Umar Farooq
Director
Company Registration No. 13498615
Farooq Pharma Ltd
Notes to the Accounts
for the year ended 31 July 2025
Farooq Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 13498615. The registered office is 94 Park Lea, Huddersfield, West Yorkshire, HD2 1QP, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25% on cost
Fixtures & fittings
25% on cost.
Computer equipment
25% on cost
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
4
Tangible fixed assets
Total
Farooq Pharma Ltd
Notes to the Accounts
for the year ended 31 July 2025
5
Average number of employees
During the year the average number of employees was 1 (2024: 1).